• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NVAX:US

4.6200 USD 0.1100 2.33%

As of 20:10:00 ET on 08/28/2014.

Company Profile for Novavax Inc (NVAX)

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Contact Information

Novavax Inc

9920 Belward Campus Drive
Rockville, MD 20850
United States
Phone: 1-240-268-2000

Key Executives for Novavax Inc (NVAX)

Stanley C ErckPresident/CEOBarclay A Phillips "Buck"Senior VP/CFO/Treasurer
Russell P Wilson "Rip"Senior VP:Business DevelopmentJohn J TrizzinoSenior VP:Commercial Operations
Timothy J HahnSenior VP:ManufacturingCynthia N Oliver "Cindy"Senior VP:Process Dev Ops
Gregory M Glenn "Greg"Senior VP:Research & DevelopmentLouis Fries III "Lou"VP/Chief Medical Officer
D Nigel ThomasVP:Clinical Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil